Different mechanisms underlie IL-6 release in chemosensitive and chemoresistant ovarian carcinoma cells.
Margot De Marco(University of Salerno), Liberato Marzullo(University of Salerno), Antonio Mollo(Northwestern University), Maria Pascale(University of Salerno), Antonia Falco(University of Salerno), Francesco Antonio Salzano(University of Salerno), Fulvio Zullo(Magna Graecia University), Danilo Swann Matassa(Federico II University Hospital), Alessandra Rosati(University of Salerno), Anna Lisa Cammarota(University of Salerno), Antonio Raffone(University of Campania "Luigi Vanvitelli"), Antonio Travaglino(University of Insubria), Lucia Sandullo(University of Salerno), Mario Capunzo, Francesca Reppucci(University of Salerno), Maurizio Guida(University of Naples Federico II), Rosanna Martinelli(University of Salerno), Franca Esposito(Federico II University Hospital), Michela Festa(Ospedale Monaldi), Paolo Remondelli(University of Salerno)
PubMed
January 1, 2020
Cited by 5
Related Papers
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|281
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
|The Journal of Clinical Endocrinology & Metabolism|2004|276
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|254